Bruno, Christopher D <br/><br/>
HLA associations with infliximab-induced liver injury.  [electronic resource] 

 -  The pharmacogenomics journal  10 2020 
 - 681-686 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1473-1150 
<br/><br/><label>Standard No.: </label>10.1038/s41397-020-0159-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Anti-Inflammatory Agents--adverse effects<br/>Chemical and Drug Induced Liver Injury--diagnosis<br/>Child<br/>Female<br/>Genome-Wide Association Study<br/>HLA Antigens--genetics<br/>HLA-B39 Antigen--genetics<br/>HLA-B8 Antigen--genetics<br/>HLA-DQ beta-Chains--genetics<br/>HLA-DRB1 Chains--genetics<br/>Humans<br/>Infliximab--adverse effects<br/>Male<br/>Middle Aged<br/>Pharmacogenetics<br/>Pharmacogenomic Variants<br/>Phenotype<br/>Polymorphism, Single Nucleotide<br/>Retrospective Studies<br/>Risk Assessment<br/>Risk Factors<br/>Young Adult